Inhibition of methyltransferase reduces the turnover of acetylcholine receptors

R. W. Kuncl, Daniel B Drachman, R. Adams

Research output: Contribution to journalArticle

Abstract

Because of the putative rule of phospholipid methyltransferase reactions in many important membrane and receptor translocation processes, we studied the effect of methyltransferase inhibitors on acetylcholine receptor (AcChoR) turnover in cultured rat skeletal muscle. Inhibition of methyltransferase significantly reduced the normal rate of degradation of AcChoRs, a process that involves endocytosis. Further, under conditions that greatly accelerate the rate of degradation of AcChoRs - i.e., by addition of anti-AcChoR antibody - methyltransferase inhibitors again significantly reduced receptor turnover. AcChoR synthesis was unaffected. Thus, the net effect of this treatment was slowing of the antibody-induced loss of surface AcChoRs. That this drug effect was mediated specifically by inhibition of methylation reactions was suggested by certain additional pharmacologic features: partial reversibility of the effect by methionine, enhancement by homocysteine, and correspondence with marked inhibition of phospholipid methylation. The substrate specificity of the methyltransferase inhibitors capable of reducing AcChoR degradation suggests that phospholipid methylation reactions may be most relevant. Methyltransferase inhibitor drugs may provide a therapeutic strategy in receptor disorders such as myasthenia gravis, in which accelerated receptor endocytosis plays a major role.

Original languageEnglish (US)
Pages (from-to)4032-4036
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume85
Issue number11
StatePublished - 1988

Fingerprint

Methyltransferases
Cholinergic Receptors
Methylation
Endocytosis
Phosphatidyl-N-Methylethanolamine N-Methyltransferase
Phospholipids
Antibodies
Myasthenia Gravis
Homocysteine
Substrate Specificity
Pharmaceutical Preparations
Methionine
Skeletal Muscle
Membranes

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Inhibition of methyltransferase reduces the turnover of acetylcholine receptors. / Kuncl, R. W.; Drachman, Daniel B; Adams, R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 85, No. 11, 1988, p. 4032-4036.

Research output: Contribution to journalArticle

@article{3703ee39b6dc436483d0100b6709b9bb,
title = "Inhibition of methyltransferase reduces the turnover of acetylcholine receptors",
abstract = "Because of the putative rule of phospholipid methyltransferase reactions in many important membrane and receptor translocation processes, we studied the effect of methyltransferase inhibitors on acetylcholine receptor (AcChoR) turnover in cultured rat skeletal muscle. Inhibition of methyltransferase significantly reduced the normal rate of degradation of AcChoRs, a process that involves endocytosis. Further, under conditions that greatly accelerate the rate of degradation of AcChoRs - i.e., by addition of anti-AcChoR antibody - methyltransferase inhibitors again significantly reduced receptor turnover. AcChoR synthesis was unaffected. Thus, the net effect of this treatment was slowing of the antibody-induced loss of surface AcChoRs. That this drug effect was mediated specifically by inhibition of methylation reactions was suggested by certain additional pharmacologic features: partial reversibility of the effect by methionine, enhancement by homocysteine, and correspondence with marked inhibition of phospholipid methylation. The substrate specificity of the methyltransferase inhibitors capable of reducing AcChoR degradation suggests that phospholipid methylation reactions may be most relevant. Methyltransferase inhibitor drugs may provide a therapeutic strategy in receptor disorders such as myasthenia gravis, in which accelerated receptor endocytosis plays a major role.",
author = "Kuncl, {R. W.} and Drachman, {Daniel B} and R. Adams",
year = "1988",
language = "English (US)",
volume = "85",
pages = "4032--4036",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

TY - JOUR

T1 - Inhibition of methyltransferase reduces the turnover of acetylcholine receptors

AU - Kuncl, R. W.

AU - Drachman, Daniel B

AU - Adams, R.

PY - 1988

Y1 - 1988

N2 - Because of the putative rule of phospholipid methyltransferase reactions in many important membrane and receptor translocation processes, we studied the effect of methyltransferase inhibitors on acetylcholine receptor (AcChoR) turnover in cultured rat skeletal muscle. Inhibition of methyltransferase significantly reduced the normal rate of degradation of AcChoRs, a process that involves endocytosis. Further, under conditions that greatly accelerate the rate of degradation of AcChoRs - i.e., by addition of anti-AcChoR antibody - methyltransferase inhibitors again significantly reduced receptor turnover. AcChoR synthesis was unaffected. Thus, the net effect of this treatment was slowing of the antibody-induced loss of surface AcChoRs. That this drug effect was mediated specifically by inhibition of methylation reactions was suggested by certain additional pharmacologic features: partial reversibility of the effect by methionine, enhancement by homocysteine, and correspondence with marked inhibition of phospholipid methylation. The substrate specificity of the methyltransferase inhibitors capable of reducing AcChoR degradation suggests that phospholipid methylation reactions may be most relevant. Methyltransferase inhibitor drugs may provide a therapeutic strategy in receptor disorders such as myasthenia gravis, in which accelerated receptor endocytosis plays a major role.

AB - Because of the putative rule of phospholipid methyltransferase reactions in many important membrane and receptor translocation processes, we studied the effect of methyltransferase inhibitors on acetylcholine receptor (AcChoR) turnover in cultured rat skeletal muscle. Inhibition of methyltransferase significantly reduced the normal rate of degradation of AcChoRs, a process that involves endocytosis. Further, under conditions that greatly accelerate the rate of degradation of AcChoRs - i.e., by addition of anti-AcChoR antibody - methyltransferase inhibitors again significantly reduced receptor turnover. AcChoR synthesis was unaffected. Thus, the net effect of this treatment was slowing of the antibody-induced loss of surface AcChoRs. That this drug effect was mediated specifically by inhibition of methylation reactions was suggested by certain additional pharmacologic features: partial reversibility of the effect by methionine, enhancement by homocysteine, and correspondence with marked inhibition of phospholipid methylation. The substrate specificity of the methyltransferase inhibitors capable of reducing AcChoR degradation suggests that phospholipid methylation reactions may be most relevant. Methyltransferase inhibitor drugs may provide a therapeutic strategy in receptor disorders such as myasthenia gravis, in which accelerated receptor endocytosis plays a major role.

UR - http://www.scopus.com/inward/record.url?scp=0023952235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023952235&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 4032

EP - 4036

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -